Influenza A+B & COVID-19 Ag Combo Test

The Influenza A+B & COVID-19 Ag Combo Test is an in vitro immunochromatographic assay for the qualitative and differential detection of nucleocapsid protein antigen from influenza A (including the subtype H1N1), influenza B and/or SARS-CoV-2 in nasopharyngeal (NP) swab specimens. It is intended to aid in the rapid diagnosis of influenza A, influenza B and/or SARS-CoV-2 infections. This test provides only a preliminary test result.



Influenza A: sensitivity -99.2%,specificity - 99.6%,total agreement - 99.5%

Influenza B : sensitivity -99.1%,specificity - 99.8%,total agreement - 99.7%

COVID-19 Ag:sensitivity -98.1%,specificity - 99.6%,total agreement - 99.2%

√Fast to read result

√High accuracy

√Convenient to use

This test has not been authorized for use by the FDA and is not available in the United States.